Century Therapeutics (IPSC) Earnings Date, Estimates & Call Transcripts $0.53 -0.03 (-5.36%) Closing price 03:59 PM EasternExtended Trading$0.54 +0.01 (+1.69%) As of 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Century Therapeutics Earnings Summary Upcoming Earnings DateMay. 8Before Market OpensEstimatedConsensus EPS (Mar. 19) -$0.45 Actual EPS (Mar. 19) -$0.43 Beat By $0.02 Actual Revenue (Mar. 19) $4.18MCentury Therapeutics announced Q4 2024 earnings on March 19, 2025, reporting an EPS of -$0.43, which beat the consensus estimate of -$0.45 by $0.02. Quarterly revenue was reported to be $4.18 million, above analysts' expectations of $0.67 million. With a trailing EPS of -$1.63, Century Therapeutics' earnings are expected to decrease next year, from ($1.61) to ($1.79) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Annual Report (10-K) Press Release (8-K)IPSC Upcoming EarningsCentury Therapeutics' Q1 2025 earnings is scheduled for Thursday, May 8, 2025, with a conference call scheduled on Monday, May 12, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Century Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Century Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataIPSC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IPSC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Century Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.45-$0.40-$0.42Q2 20253-$0.44-$0.40-$0.42Q3 20253-$0.44-$0.41-$0.43Q4 20253-$0.46-$0.42-$0.44 FY 2025 12 -$1.79 -$1.63 -$1.71 Q1 20261-$0.46-$0.46-$0.46Q2 20261-$0.47-$0.47-$0.47Q3 20261-$0.47-$0.47-$0.47Q4 20261-$0.48-$0.48-$0.48 Century Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)--------3/19/2025Q4 2024-$0.45-$0.43+$0.02-$0.43$0.67M$4.18M11/5/2024Q3 2024-$0.45-$0.37+$0.08-$0.37$0.47M$0.79M8/8/2024--$0.50-$0.38+$0.12-$0.38$0.55M$0.77M5/9/2024Q1 2024-$0.50-$0.45+$0.05-$0.45$0.30M$0.86M3/14/2024Q4 2023-$0.56-$0.49+$0.07-$0.33$1.69M$0.27M11/9/2023Q3 2023-$0.53-$0.55 -$0.02-$0.55$1.08M$0.15M8/9/2023Q2 2023-$0.54-$0.56 -$0.02-$0.56$1.54M$0.10M5/11/2023Q1 2023-$0.53-$0.53--$0.53$2.26M$1.72M Century Therapeutics Earnings - Frequently Asked Questions When is Century Therapeutics's earnings date? Century Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on IPSC's earnings history. Did Century Therapeutics beat their earnings estimates last quarter? In the previous quarter, Century Therapeutics (NASDAQ:IPSC) reported ($0.43) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.45) by $0.02. Learn more on analysts' earnings estimate vs. IPSC's actual earnings. How much revenue does Century Therapeutics generate each year? Century Therapeutics (NASDAQ:IPSC) has a recorded annual revenue of $6.59 million. How much profit does Century Therapeutics generate each year? Century Therapeutics (NASDAQ:IPSC) has a recorded net income of -$136.67 million. IPSC has generated -$1.63 earnings per share over the last four quarters. What is Century Therapeutics's EPS forecast for next year? Century Therapeutics's earnings are expected to decrease from ($1.61) per share to ($1.79) per share in the next year. More Earnings Resources from MarketBeat Related Companies ACIU Earnings MOLN Earnings KRRO Earnings IKT Earnings PRQR Earnings TNGX Earnings FDMT Earnings LFVN Earnings LRMR Earnings PBYI Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Palantir Stock Drops Despite Stellar Earnings: What's Next?Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 This page (NASDAQ:IPSC) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump's tariffs on China have caused a ripple effect across global markets. But in crypto? They've lit a fu...Crypto 101 Media | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredREVEALED: Elon’s Secret Master Plan “AGENDA X”REVEALED: Elon's Secret Master Plan "AGENDA X" For almost 30 years, Elon worked on his master plan in secre...Brownstone Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Century Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Century Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IPSC Stock Free IPSC Stock Alerts